Dexcom, Inc., a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced that Health Canada has approved the next-generation Dexcom G7 Continuous Glucose Monitoring System for people with all types of diabetes, ages two years and older.
Diabetes is a complex and burdensome condition affecting more than 3 million Canadians. It requires around-the-clock management of glucose levels and daily treatment decisions to manage the disease. Health Canada approval of Dexcom G7 gives Canadians access to a game changing technology that makes managing diabetes easier, and has been shown to reduce hospitalizations and emergency room visits due to hypoglycaemia by up to 42 per cent.
